tiprankstipranks

Frank Litvack Insider Profile

4 Followers
Frank Litvack, Director at Capricor Therapeutics, holds 133.27K shares in Capricor Therapeutics (Ticker: CAPR).
tipranks
Frank Litvack

Frank Litvack
Capricor Therapeutics (CAPR)
Director

Not Ranked
Frank Litvack has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$642K
100.00%
A breakdown of Frank Litvack's holdings

Insider Roles

Capricor Therapeutics
(CAPR)
Director
Roles that Frank Litvack holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Frank Litvack

Frank Litvack's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Capricor Therapeutics
Aug 16, 2023
Director
Uninformative Sell
28.85K
$642.36K
Frank Litvack has not reported any informative transactions for CAPR, therefore, performance cannot be measured.
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Aug 16, 2023
Uninformative Sell
$28.85K
-
$1.39
Dec 19, 2019
Uninformative Buy
$0.00
-
$0.00
Feb 23, 2023
Uninformative Sell
$19.50K
-
$1.39
Jan 04, 2022
Uninformative Sell
$214.82K
-
$1.39
List of latest transactions for each holding click on a transaction to see Frank Litvack's performance on stock

Frank Litvack insider profile FAQ

What is the percentage of profitable transactions made by Frank Litvack?
The percentage of profitable transactions made by Frank Litvack is ―.
    What is the average return per transaction made by Frank Litvack?
    The average return per transaction made by Frank Litvack is ―.
      What stocks does Frank Litvack hold?
      Frank Litvack holds: CAPR stocks.
        What was Frank Litvack’s latest transaction?
        Frank Litvack latest transaction was an Uninformative Sell of $28.85K.
          What was Frank Litvack's most profitable transaction?
          Frank Litvack’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Frank Litvack's role in Capricor Therapeutics?
            Frank Litvack's role in Capricor Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.